Form 4: Teradyne Director Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Teradyne Director Mercedes Johnson sold 625 shares of common stock for $266.98 per share on February 5, 2026, under a pre-arranged 10b5-1 trading plan.
Summary
- Mercedes Johnson, a Director of Teradyne, Inc. (TER), executed a sale of common stock.
- On February 5, 2026, Johnson disposed of 625 shares of Teradyne common stock.
- The shares were sold at a price of $266.98 per share.
- This transaction was conducted pursuant to a Rule 10b5-1 sales plan adopted by Johnson on February 3, 2025.
- Following the transaction, Mercedes Johnson directly beneficially owns 7,613 shares of Teradyne common stock.
- Additionally, 1,876 shares are indirectly beneficially owned by The Mercedes Johnson Trust UAD 07/23/04, for which Johnson is the trustee and sole beneficiary.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a neutral-to-slightly-negative event. While it represents a reduction in direct insider ownership, the execution under a pre-arranged 10b5-1 plan suggests it is not an opportunistic sale based on new, adverse information.
Positives
- The sale was executed under a pre-arranged Rule 10b5-1 trading plan, indicating the transaction was not based on new, non-public information and was scheduled in advance.
Negatives
- An insider selling shares, even under a pre-arranged plan, reduces their direct ownership stake and can be perceived as a slight negative signal regarding future stock price appreciation.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that insider sales, even when executed under Rule 10b5-1 plans, are routinely monitored by investors for potential signals regarding management's confidence. However, the pre-planned nature of such sales generally mitigates immediate concerns of opportunistic selling based on undisclosed negative information.
Stakeholder Impact
- Shareholders may perceive a slight negative signal from the reduction in direct insider ownership, although the pre-planned nature of the sale under a 10b5-1 plan typically lessens the impact compared to an unplanned sale.
Key Dates
| Date | Description |
|---|---|
| 07/23/2004 | Date of the Trust Under Agreement (UAD) for The Mercedes Johnson Trust |
| 02/03/2025 | Date the Rule 10b5-1 sales plan was adopted by Mercedes Johnson |
| 02/05/2026 | Date of the reported transaction (sale of common stock) |
| 02/06/2026 | Date the Form 4 filing was signed and filed |
Recommendation
holdThe sale of 625 shares by a director, executed under a pre-arranged 10b5-1 plan, is a routine event and does not provide new material information to warrant a change in investment thesis. Investors should continue to monitor overall insider activity and company fundamentals.
Keywords
Teradyne, TER, Form 4, insider trading, stock sale, Mercedes Johnson, 10b5-1 plan, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.